The $29 Billion March Wasn’t a Spike — It’s the Opening Bid for a Restructured Industry
Seven biopharma deals worth $29 billion closed in the final two weeks of March 2026. The street called it...
Biopharma Dealmaking
Seven biopharma deals worth $29 billion closed in the final two weeks of March 2026. The street called it...